TheJAK2V617Fmutation and thrombosis-Reference-Cited by-同舟云学术

TheJAK2V617Fmutation and thrombosis

Published:2008-11 Issue:3 Volume:143 Page:307-320
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Austin S. K.,Lambert J. R.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07258.x/fullpdf

Reference92 articles.

1. Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients;Alvarez-Larran;Leukemia,2007

2. Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis;Alvarez-Larran;Annals of Hematology,2008

3. Clinical implications of the JAK2 V617F mutation in essential thrombocythemia;Antonioli;Leukemia,2005

4. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status;Arellano-Rodrigo;Haematologica,2006

5. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK2-V617F-mutated myeloproliferative neoplasms: A cannot be missed cause of symptomatic postoperative epidural hematoma after lumber spine surgery;European Journal of Internal Medicine;2024-01

2. A Journey from Appendicitis to a Rare Appendiceal Mucinous Neoplasm;Journal of Community Hospital Internal Medicine Perspectives;2023-11-04

3. Pan-HDAC inhibitors augment IL2-induced proliferation of NK cells via the JAK2-STAT5B signaling pathway;International Immunopharmacology;2023-03

4. Clinical Application of Biomarkers for Hematologic Malignancies;Biomarkers in Medicine;2022-08-30

5. Vascular Endothelial Dysfunction in Myeloproliferative Neoplasms and Gene Mutations;International Heart Journal;2022-07-30